Taiwan FDA registration dafe8cfce3bae5c8be7b1ed736c8ffb0
Reva Steinberg Method's top blood gas and electrolyte analyzer
TW: 露華史丹伯法頂級血液氣體與電解質分析儀
Taiwan·Risk Class 2·NOVA BIOMEDICAL CORPORATION·Registered Feb 24, 2016 – Feb 24, 2026ExpiredRegistration details
- Analysis ID
- dafe8cfce3bae5c8be7b1ed736c8ffb0
- Customs Code
- DHA05602809605
Company information
- Manufacturer
- NOVA BIOMEDICAL CORPORATION
- Manufacturer Country
- United States
- Authorized Representative
- BEAM INTERNATIONAL INC.
Product details
- Intended Use
- Quantification of pH, PCO2, PO2, cell volume ratio (Hct), Na+, K+, Cl-, Ca2+, glucose (Glu) and lactic acid (Lac) in whole blood containing heparin.
- Product Type (Level 1)
- A Clinical chemistry and clinical toxicology
- Product Type (Level 2)
- A.1170 Chloride test system;; A.1345 Glucose Test System;; A.1145 Calcium Test System
- Import Information
- import
Dates and status
- Registration Date
- Feb 24, 2016
- Expiry Date
- Feb 24, 2026
About this record
Access comprehensive regulatory information for Reva Steinberg Method's top blood gas and electrolyte analyzer in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number dafe8cfce3bae5c8be7b1ed736c8ffb0 and manufactured by NOVA BIOMEDICAL CORPORATION. The authorized representative in Taiwan is BEAM INTERNATIONAL INC..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices